Manufactured by Summit, N.J.-based Celgene Corp., Otezla demonstrated improvements in symptoms of psoriatic arthritis, such as tender and swollen joints and physical function, in clinical trials.
More Articles on FDA Approvals:
FDA Approves Xolair for Chronic Hives
FDA Approves Neuraceq for Brain Imaging
FDA Approves Implantable Device for Certain Type of Hearing Loss
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.